CellVoyant leverages AI and live-cell imaging to predict cellular behavior, transforming cell therapy development and making ...

was awarded to the King Faisal Specialist Hospital & Research Centre for revolutionising organ transplantation through ...

David M. Weiner, MD, Rejoins Chemomab as Interim Chief Medical Officer, Bringing Extensive Biotechnology and Pharmaceutical ...

The company's cancer cell therapy Carvykti, which it makes in partnership with Legend Biotech, brought in sales of $369 million, above estimates of $324 million. Quarterly sales of J&J's cancer drugs ...

Keith Coursin, Vonnie Estes, Patrick Hidder, Andrew Horowitz, Julia Kurnik and Michael Yates are joining the board to help ...

New York State is a top recipient of NIH funding and is expected to lose about $880 million.

Mark Esser, an executive at Big Pharma firm AstraZeneca, has been named the inaugural leader of UVa's future Manning ...

Swiss pharmaceutical giant Novartis announced it will spend $23 billion to build and expand 10 facilities in the United ...

For the second consecutive year, U.S. News & World Report has named Western University of Health Sciences' College of ...

We deeply mourn the passing of R.W. – our family patriarch and one of the visionaries behind Kemin. He was beloved by our ...

Clearmind Medicine (CMND) has initiated its Phase I/IIa clinical trial at its first U.S. clinical site, the Johns Hopkins University School of ...

A new study in the peer-reviewed journal Stem Cells and Development highlights the potential of mesenchymal stem cell (MSC)-derived extracellular vesicles (EVs) as a therapeutic strategy for high-dose ...